Exit Readiness Validation — Helix Health Technologies

Prepared by: Layer8TechGroup · Framework: 10 Technology Fixes · Documents Ingested: 11

Overall Score

5.8/10

8-domain blend

Buyer Discount Risk

Moderate

Needs Preparation

EBITDA

$820,000

most recent FY

Vertical

Healthcare

healthcare

Assessment Scores — 8-Domain Profile

DRDiligence Risk

5.3/10NEEDS WORK

OROwner Risk

5.0/10NEEDS WORK

CQCustomer Quality

6.8/10ADEQUATE

OSOperational Scalability

4.5/10NEEDS WORK

FRFinancial Readiness

6.2/10ADEQUATE

LCLegal & Regulatory Compliance

6.5/10ADEQUATE

TMTechnology & Systems Maturity

5.5/10ADEQUATE

HCHuman Capital

5.7/10ADEQUATE

Buyer Discount Risk

EBITDA (most recent FY): $820,000 (AI-extracted) · Exit Readiness: 5.8/10 — Needs Preparation

Score	Band	Buyer Discount Risk
8.0 – 10.0	Institutional Ready	Minimal — few gaps for buyers to exploit
6.5 – 7.9	Market Ready	Low — some negotiating leverage for buyers
5.0 – 6.4	Needs Preparation	Moderate — expect re-trade attempts
3.5 – 4.9	Material Gaps	High — significant discount likely
Below 3.5	Not Ready	Very High — consider delaying go-to-market

Scores reflect readiness relative to what buyers examine in diligence — not a valuation guarantee. For a specific valuation range, share your Exit Readiness Score with your broker or M&A advisor.

↑ What strengthens your position

Insurance contract transferability
Patient retention rate and recall systems
Provider succession plan documented
No-show rate below 8%

↓ What buyers will flag

Single provider dependency
Payer concentration >50% one insurer
Undocumented compliance posture

Top 3 Strengths

CQCustomer Quality at 6.8/10 (ADEQUATE) demonstrates an adequate foundation of customer relationships and retention that will reduce a buyer's perceived risk of revenue leakage post-close. This adequate profile preempts common diligence concerns around customer concentration and churn, limiting the scope for discount demands tied to customer stability and allowing management to defend against re-trade attempts rooted in revenue durability.
LCLegal & Regulatory Compliance at 6.5/10 (ADEQUATE) reflects an adequate posture on regulatory obligations and legal exposure in the healthcare vertical, where compliance gaps are a primary source of buyer discount requests. This adequate standing will constrain a purchaser's ability to demand price concessions based on unresolved compliance or licensing liabilities, strengthening Helix's negotiating position as diligence unfolds.

Top 3 Risks

OROwner Risk at 5.0/10 (NEEDS WORK) represents a critical gap that will trigger a buyer discount during diligence. Buyers will conduct extensive validation around founder dependencies, knowledge concentration, and post-close continuity commitments, and any material owner-centric operational or client relationships will create re-trade leverage for the acquirer. This needs-work posture in a healthcare exit typically surfaces as a price concession or extended earnout clawbacks tied to owner retention.
DRDiligence Risk at 5.3/10 (NEEDS WORK) creates a material liability during the buyer's due diligence phase and will likely trigger cost-of-sale and timeline friction. Gaps in financial documentation, data integrity, or operational transparency in a healthcare company will prompt detailed secondary diligence, regulatory review, and representations and warranties coverage requests that increase deal friction and buyer discount expectations. This needs-work profile signals that preparation work is required before approaching the market.
OSOperational Scalability at 4.5/10 (NEEDS WORK) poses a deal-completion risk because buyers will question whether current operations can support growth or integration post-close without material reinvestment. In healthcare, scalability gaps often surface as concerns around compliance infrastructure, staffing models, or system capacity, all of which create post-close liability assumptions that buyers will require pricing concessions to absorb. This critical gap will require remediation or a detailed integration plan before listing to avoid buyer discount expectations.

Recommended Priority Fixes

The five highest-priority actions for the next 90 days, ranked by deal impact. For the complete domain-by-domain remediation plan and cost estimates, see the Value Recovery Roadmap below.

Fix 1OR

Document founder dependencies and create transition plan

Map all founder-held client relationships, operational knowledge, and decision authority; produce a written 24-month post-close continuity plan showing how each dependency transfers to key staff or documented process. Addresses Owner Risk (5.0/10). Buyers will scrutinize founder-centric risk and use any undocumented dependencies as re-trade leverage; a clear transition roadmap removes a primary discount driver.

Fix 2DR

Audit financial records and produce diligence data room

Engage a third-party accountant to validate three years of tax returns, revenue recognition, and expense allocation; produce a clean, indexed data room with audited financials, customer contracts, and a reconciliation narrative addressing any prior-year restatements or anomalies. Addresses Diligence Risk (5.3/10). Healthcare buyers conduct rigorous secondary diligence on financial integrity and regulatory compliance; gaps in documentation trigger costly escrow holdbacks and buyer requests for representations and warranties insurance, both of which compress deal economics.

Fix 3OS

Build scalability roadmap for compliance and staffing

Document current compliance infrastructure (regulatory workflows, audit trails, staff certification requirements) and staffing model; produce a written growth integration plan showing how Helix can support 50% revenue growth without regulatory breach or team breakdown. Addresses Operational Scalability (4.5/10). Buyers will assume post-close reinvestment is needed unless operations are proven modular; a credible scalability plan reduces buyer concerns about hidden integration costs and compliance liability absorption, protecting deal valuation.

Fix 4HC

Recruit or transition key clinical or operational leader

Hire or internally promote a Chief Operating Officer, Clinical Director, or VP Operations with healthcare delivery experience and independent decision authority; ensure this leader owns at least two customer relationships and one major operational function by Day 60. Addresses Human Capital (5.7/10). A visible senior hire signals operational maturity and reduces buyer concern that the company is founder-driven; this strengthens the team narrative and limits re-trade leverage tied to staffing risk.

Fix 5TM

Commission cybersecurity and data governance assessment

Engage a healthcare-focused security firm to audit patient data handling, system access controls, and HIPAA compliance posture; deliver a written gap report with a 90-day remediation roadmap and cost estimate. Addresses Technology & Systems Maturity (5.5/10). Healthcare buyers conduct deep technology diligence and view security gaps as material liability; a proactive third-party assessment demonstrates governance rigor and reduces buyer risk perception, preventing discounts tied to unvalidated compliance or system maturity concerns.

Domain Detail & Findings

DRDiligence Risk5.3/10 NEEDS WORK (17% blend)

Evidence coverage: scored on 7 of 7 criteria

Judged, not computed — these criteria await a document-type classifier

Deal Impact: Documentation gaps will extend diligence and require owner availability — expect timeline pressure and buyer discount attempts.

ID	Criterion & Finding	Score	Rating
dr_01	Tier A Document Set Completeness Document evidence HTS_Employee_Roster.csv · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_HC_Profile.txt · HTS_GL_Export.csv Helix Health Technologies has filed an employee roster with 18 full-time staff and hire dates, one executed customer contract (Metro Orthopedic Group at $192,000 annual value), general ledger entries from March 2025, and a human capital profile documenting compensation structures and benefits portability. However, the data room is missing financial statements, tax returns, corporate formation records (operating agreement details are referenced but not filed), a complete customer contract set (only one of multiple clients is represented), and insurance certificates (only referenced as portable in the HC profile, not actually filed).	5/10	NEEDS WORK
dr_02	Evidence Currency Document evidence HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Employee_Roster.csv · HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt · HTS_CIM.txt Helix Health Technologies' primary dated artifacts are current and aligned with buyer expectations. The Cybersecurity & Compliance Assessment is dated January 2026, the Human Capital Profile is dated April 2026, the Confidential Information Memorandum is dated April 2026, and the Metro Orthopedic customer contract is dated March 1, 2024 (within acceptable range for an active recurring agreement). The only forward-looking gap is the recommendation to complete SOC 2 Type II audit with a target of Q3 2026, which is a planned future deliverable rather than a stale or missing current certification.	8/10	STRONG
dr_03	Substantiation of Stated Figures Document evidence HTS_Cybersecurity_Assessment.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Employee_Roster.csv · HTS_GL_Export.csv Helix Health Technologies does not substantiate its headline figures with traceable source documents. The retrieved materials include a cybersecurity assessment naming 42 clients and referencing 18 staff members, a customer onboarding SOP, an employee roster excerpt with redacted names, and a general ledger export showing individual transactions from January–February 2025, but none of these documents present aggregated figures for revenue, EBITDA, headcount, customer count, or retention. The GL export shows transaction-level line items (e.g., $18,000 consulting invoice, $9,500 SaaS fee, $84,000 payroll) without monthly or annual summaries, and the cybersecurity assessment mentions "42 covered entity clients" in passing but provides no customer retention metric or total headcount count verified across the full organization.	3/10	CRITICAL RISK
dr_04	Corporate Records Completeness Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_CIM.txt · HTS_Cybersecurity_Assessment.txt · HTS_Financials.csv Helix Health Technologies LLC is organized as a Georgia limited liability company with documented formation and operating agreement provisions (evidenced by references to Class B profits interest, change-of-control acceleration triggers, and guaranteed payment arrangements for Dr. A key employee). However, the retrieved documents do not provide evidence of a current capitalization table, complete governance records, or board/member meeting minutes; while equity arrangements for the CTO (8% economic interest) and guaranteed payments are mentioned, no comprehensive cap table showing all ownership interests and fully executed governing documents are included in the materials provided.	6/10	ADEQUATE
dr_05	Contract File Completeness Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_CRM_Pipeline.csv · HTS_Customer_Onboarding_SOP.txt · HTS_Employee_Roster.csv Helix Health Technologies has executed a Master Subscription Agreement with Metro Orthopedic Group dated March 1, 2024, signed by the CEO and filed with an incorporated Business Associate Agreement, demonstrating that at least one material customer contract exists as a complete executed copy. The company's onboarding standard operating procedure (version 3.1, October 2025) mandates that "all legal documents executed before any PHI access" during Phase 1, including MSA, Order Form, BAA, NDA, and security questionnaires, but the retrieved documents provide executed copies for only one named customer relationship despite the company managing 42 client relationships mapped to key employees.	7/10	ADEQUATE
dr_06	Employment File Completeness Document evidence HTS_HC_Profile.txt · HTS_Employee_Roster.csv · HTS_Customer_Onboarding_SOP.txt · HTS_Cybersecurity_Assessment.txt Helix Health Technologies maintains an employee roster with 18 staff members documenting names, roles, departments, salaries, hire dates, and reporting structure, along with a documented 8-week onboarding program for technical and implementation staff. However, the company lacks filed offer letters or employment agreements, an employee handbook, a formal organizational chart, and eligibility records; the documents reference only a roster and onboarding SOPs without evidence of individual offer letters, centralized handbook, or formal eligibility documentation.	5/10	NEEDS WORK
dr_07	Data Room Organisation & Access Document evidence HTS_Employee_Roster.csv · HTS_Cybersecurity_Assessment.txt · HTS_CRM_Pipeline.csv · HTS_Customer_Contract_MetroOrthopedic.txt Helix Health Technologies' filed material exists as a scattered collection of documents with inconsistent naming and minimal discernible structure—the retrieved excerpts include employee rosters, cybersecurity assessments, CRM pipeline data, and customer contracts presented as flat files with generic source labels (e.g., "HTS_Employee_Roster.csv", "HTS_Cybersecurity_Assessment.txt") that provide no organizing index or navigation guide. A buyer would need to request documents reactively for each information category rather than navigating a pre-assembled, labelled structure; there is no evidence of a centralized data room with hierarchical organization, consistent file naming conventions that identify content, or documented access protocols that would permit selective, granular disclosure without requiring manual reassembly.	3/10	CRITICAL RISK

OROwner Risk5.0/10 NEEDS WORK (16% blend)

Evidence coverage: scored on 4 of 4 criteria

Deal Impact: Owner dependency creates integration risk — expect R&W scrutiny and potential purchase-price adjustment.

ID	Criterion & Finding	Score	Rating
owr_01	Succession Readiness Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Employee_Roster.csv · HTS_CIM.txt Helix Health Technologies has no formal succession plan documented, and critical knowledge and client relationships remain heavily concentrated with the founder and CTO. While the company successfully operated through a 4-week founder absence in Q3 2025 with key employees managing externally and internally, the CIM explicitly identifies "Founder dependency — Dr. A key employee is primary relationship holder for 28 of 42 clients and leads all sales conversations" and notes that "a key employee (CTO) holds all EHR integration architecture knowledge; no technical succession plan" exists, creating significant transition risk for an acquirer.	4/10	NEEDS WORK
owr_02	Institutional Knowledge Capture Document evidence HTS_Customer_Onboarding_SOP.txt · HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt · HTS_CRM_Pipeline.csv Helix Health Technologies has documented critical client onboarding and technical processes in versioned SOPs (Customer Onboarding SOP v3.1, last updated October 2025) and an 8-week new-hire onboarding program for technical and implementation staff, enabling the company to survive a 4-week founder absence in Q3 2025 without client disruption. However, institutional knowledge remains concentrated in key individuals: the CTO holds architectural knowledge and critical vendor relationships (Epic integration, AWS HIPAA environment), and Dr. A key employee personally leads enterprise deal closure and annual client renewals, creating single points of failure despite documented process frameworks and successful client relationship transfers to the VP CS team across 42 accounts.	5/10	NEEDS WORK
owr_03	Management Team Depth Document evidence HTS_HC_Profile.txt · HTS_Cybersecurity_Assessment.txt · HTS_Customer_Onboarding_SOP.txt Helix Health Technologies has a functional management layer with qualified leaders across most key areas: the VP Customer Success has operated independently for 12 months with all 42 client relationships mapped to her team, and the company successfully operated for 4 weeks during a founder absence in Q3 2025 without client disruption. However, the CTO holds critical architectural knowledge and key vendor relationships (Epic integration, AWS HIPAA environment) that represent a primary technical risk, and the founder retains control of enterprise deal closures, creating dependency points that limit full operational independence.	7/10	ADEQUATE
owr_04	Key Person Concentration Beyond Owner Document evidence HTS_Employee_Roster.csv · HTS_HC_Profile.txt · HTS_CRM_Pipeline.csv Helix Health Technologies has concentrated key person risk beyond the owner in two critical areas. The CTO holds architectural knowledge and exclusive vendor relationships (Epic integration, AWS HIPAA environment) with only a Senior Software Engineer identified as partial backup, and Dr. A key employee (Founder/CEO) owns the majority of enterprise sales pipeline—$756,000 of $1,260,000 in qualified/proposal/negotiation deals are attributed to the founder, with limited secondary coverage documented. While the company demonstrated operational resilience during a 4-week founder absence in Q3 2025 and maintains an 8-week documented onboarding program, engineering turnover of 28% and the absence of formal succession documentation for the CTO role create material revenue and technical delivery risk.	4/10	NEEDS WORK

CQCustomer Quality6.8/10 ADEQUATE (21% blend)

Evidence coverage: scored on 4 of 4 criteria

Deal Impact: Adequate customer quality — concentration or churn risk will be modeled but is unlikely to break a deal.

ID	Criterion & Finding	Score	Rating
cq_01	Top Customer Concentration Document evidence HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Financials.csv · HTS_CIM.txt · HTS_HC_Profile.txt Helix Health Technologies demonstrates moderate customer concentration with its largest customer, Metro Orthopedic Group, representing 4.7% of FY 2025 revenue ($192,000 of $4.1M total), and the top 5 customers combining for approximately 18.4% of revenue based on the disclosed customer roster. The company serves 42 active healthcare organization clients with an average contract value of $81,600 annually, indicating meaningful revenue diversification across independent physician groups and specialty practices throughout the Southeast, with no customer dependency risk that would materially impact exit readiness.	8/10	STRONG
cq_02	Revenue Predictability & Recurring Mix Document evidence HTS_GL_Export.csv · HTS_CIM.txt · HTS_Financials.csv Helix Health Technologies derives 71% of FY2025 revenue ($2.911M) from recurring sources under annual SaaS and managed services contracts, with the top 10 customers representing 29.3% of revenue and the largest customer (Metro Orthopedic Group) contributing 4.7%. Monthly recurring revenue forecasts for 2025 show consistent, predictable growth from $228K to $250K with documented client concentration across 42 practices on annual contract terms, though the company lacks documented renewal rate metrics and faces significant key person dependency risk with one founder holding 67% of client relationships.	7/10	ADEQUATE
cq_03	Contract Transferability Document evidence HTS_Customer_Contract_MetroOrthopedic.txt · HTS_HC_Profile.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Employee_Roster.csv · HTS_CIM.txt Helix Health Technologies' Master Subscription Agreement with Metro Orthopedic Group explicitly permits assignment to a successor entity in connection with a merger or acquisition, requiring only 60 days written notice and execution of a new Business Associate Agreement by the successor, with service level maintenance required. The company has executed Business Associate Agreements with all 42 active clients and maintains a centralized onboarding process documented in its Client Onboarding SOP, establishing consistent contract administration and legal compliance infrastructure across the customer base.	9/10	STRONG
cq_04	Churn Rate & Retention Metrics Document evidence HTS_HC_Profile.txt · HTS_CIM.txt · HTS_Financials.csv · HTS_GL_Export.csv · HTS_Customer_Contract_MetroOrthopedic.txt Helix Health Technologies does not measure or track customer churn rate, retention metrics, or net revenue retention in any of the provided documentation. While the company maintains 42 active clients with 71% recurring revenue ($2.911M of $4.1M total in FY2025) and monthly recurring revenue growing from $228K to $250K across 2025, there is no evidence of formal churn tracking, root-cause analysis of customer losses, or documented retention programs or playbooks. The company's focus on customer success is evident from its dedicated VP Customer Success (5-year tenure) and implementation team, but without measurable churn data or retention metrics, exit readiness in this critical area cannot be validated.	3/10	CRITICAL RISK

OSOperational Scalability4.5/10 NEEDS WORK (8% blend)

Evidence coverage: scored on 4 of 4 criteria

Deal Impact: Technology or process gaps require post-close investment — buyers will model remediation cost into their offer.

ID	Criterion & Finding	Score	Rating
ops_01	Process Documentation & Repeatability Document evidence HTS_Cybersecurity_Assessment.txt · HTS_IT_Asset_Inventory.csv · HTS_Customer_Onboarding_SOP.txt Helix Health Technologies has documented its primary customer-facing workflow—the Client Onboarding Process (Version 3.1, October 2025)—with clear phase ownership and specific milestones across legal, technical, configuration, testing, and go-live stages. However, the SOP exhibits significant key-person dependencies: Phase 1 legal/compliance is owned by "Dr. A key employee + Priya a key employee," Phase 2 technical assessment by "a key employee (escalation)," Phase 3 platform configuration by "a key employee," and critical quarterly business reviews are led by "a key employee Winters" with annual renewals requiring "Dr. A key employee" personal engagement. The cybersecurity assessment identifies additional gaps including informal HIPAA workforce training (completion records not formally tracked), untested business continuity procedures (last tested 18 months ago), and no documented data retention policy, all of which signal that operational repeatability depends heavily on individual knowledge rather than systematized, transferable processes.	5/10	NEEDS WORK
ops_02	Technology & Systems Scalability Document evidence HTS_CRM_Pipeline.csv · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Customer_Onboarding_SOP.txt · HTS_HC_Profile.txt · HTS_GL_Export.csv · HTS_CIM.txt Helix Health Technologies operates a cloud-based SaaS platform built on AWS GovCloud with documented onboarding processes and HL7/FHIR integration capabilities across 14 EHR systems, demonstrating baseline scalability. However, the company exhibits critical technical concentration risk: the CTO holds primary architectural knowledge and key vendor relationships (Epic integration, AWS HIPAA environment), and the onboarding SOP identifies escalation ownership to "a key employee" without documented backup procedures or architectural documentation in the retrieved materials. While the platform appears capable of handling incremental growth through the existing Snowflake-based multi-tenant infrastructure, the absence of visible technical documentation, reliance on individual technical leaders for vendor relationships, and lack of evidence of automated deployment or system redundancy indicate that 3x growth would require meaningful investment in knowledge transfer and operational maturity.	6/10	ADEQUATE
ops_03	Vendor & Supplier Concentration Document evidence HTS_CIM.txt · HTS_HC_Profile.txt · HTS_Cybersecurity_Assessment.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Customer_Contract_MetroOrthopedic.txt Helix Health Technologies has critical single-source dependencies that create significant exit risk. The CTO holds all EHR integration architecture knowledge and key vendor relationships (Epic integration, AWS HIPAA environment) with no documented technical succession plan, and the company depends on 14 third-party EHR API relationships without evidence of formal alternative integrations or documented SLAs. Additionally, founder Dr. A is the primary relationship holder for 28 of 42 clients (67%) and leads all sales conversations, creating a high-risk concentration where client continuity post-close depends heavily on individual key employees rather than formalized vendor agreements or documented switching alternatives.	4/10	NEEDS WORK
ops_04	Financial Controls & Reporting Cadence Document evidence HTS_Customer_Contract_MetroOrthopedic.txt · HTS_HC_Profile.txt · HTS_Cybersecurity_Assessment.txt · HTS_Financials.csv Helix Health Technologies does not maintain documented financial controls or a defined close cadence. The retrieved financial documents (HTS_Financials.csv) contain only annual and monthly revenue summaries with no evidence of a formal close process, budget variance analysis, management review meetings, or a dedicated finance leadership role (no CFO or Controller is mentioned). The company appears to lack formal financial governance infrastructure required for M&A readiness, though the underlying revenue data itself is trackable and shows consistent growth.	3/10	CRITICAL RISK

FRFinancial Readiness6.2/10 ADEQUATE (8% blend)

Evidence coverage: scored on 4 of 4 criteria

Deal Impact: Financial presentation adequate — minor cleanup required for QofE, unlikely to cause material buyer discount.

ID	Criterion & Finding	Score	Rating
fr_01	Books Quality & CPA Relationship Document evidence HTS_Cybersecurity_Assessment.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_GL_Export.csv · HTS_Financials.csv · HTS_Customer_Onboarding_SOP.txt Helix Health Technologies engages a CPA firm for quarterly reviews at $2,400 per quarter, as documented in the GL export entries dated 2025-02-26 and referenced in ongoing OpEx:Accounting line items. The company maintains detailed general ledger exports and three-year financial summaries showing consistent revenue growth and improving EBITDA margins (18.0% to 20.0%), indicating materially accurate books; however, the documents evidence only quarterly CPA review engagement rather than audited or formally reviewed financial statements, and there is no evidence of GAAP compliance attestation or independent opinion on the financial statements.	6/10	ADEQUATE
fr_02	Add-Back Documentation Self-reported HTS_HC_Profile.txt · HTS_CIM.txt Helix Health Technologies identifies $74,000 in add-backs for FY 2025 ($48,000 founder compensation above market and $26,000 one-time legal fees), yielding normalized EBITDA of $894,000 against reported EBITDA of $820,000, but the documents provide no supporting schedules, CPA verification, or detailed substantiation of how these amounts were calculated or segregated from the financial statements. A buyer's accountant would require additional documentation to independently verify the classification of these add-backs and confirm they are properly excluded from normalized EBITDA.	5/10	NEEDS WORK
fr_03	Revenue Recognition & Consistency Document evidence HTS_CIM.txt · HTS_GL_Export.csv · HTS_Financials.csv · HTS_HC_Profile.txt Helix Health Technologies recognizes revenue across three documented categories—Recurring Revenue ($2.911M annualized), Project Revenue, and service line revenues (SaaS Platform, Integration, Consulting)—with consistent monthly tracking and year-over-year reporting showing stable gross margins at 45% for FY 2025. The general ledger excerpt demonstrates monthly invoice entries tagged by revenue type (e.g., "Revenue:SaaS Platform," "Revenue:Integration," "Revenue:Consulting") recorded on invoice dates, and the financial summary reconciles recurring and project revenue to total revenue consistently across FY 2023–2025. However, the documents do not explicitly document a formal GAAP revenue recognition policy, provide evidence of external audit attestation to revenue practices, or detail how deferred revenue or contract performance obligations are tracked, creating gaps in policy documentation and auditability.	7/10	ADEQUATE
fr_04	Three-Year Financial Trend Document evidence HTS_CIM.txt · HTS_HC_Profile.txt · HTS_Financials.csv Helix Health Technologies demonstrated revenue growth from $3.12M (FY 2023) to $4.10M (FY 2025), with EBITDA expanding from $561.6K to $820K while gross margins remained stable at 44-45% and EBITDA margins improved to 20% by FY 2025. However, revenue growth decelerated from 16.7% (FY 2024) to 12.6% (FY 2025), and normalized EBITDA of $894K includes $74K in add-backs ($48K founder compensation above market and $26K one-time legal fees), indicating some reliance on non-recurring adjustments. The recurring revenue base is strong at 71% of total revenue, though the company faces near-term execution risks including a 6-week product release delay in 2025 and 28% engineering turnover.	7/10	ADEQUATE

LCLegal & Regulatory Compliance6.5/10 ADEQUATE (11% blend)

Evidence coverage: scored on 4 of 5 criteria; 1 absent

Deal Impact: Minor compliance gaps — addressable with targeted counsel review before diligence begins.

ID	Criterion & Finding	Score	Rating
lc_01	Business Licenses & Permits No evidence submitted · withheld from score HTS_Customer_Onboarding_SOP.txt · HTS_HC_Profile.txt · HTS_CRM_Pipeline.csv · HTS_CIM.txt · HTS_Employee_Roster.csv · HTS_Cybersecurity_Assessment.txt The retrieved documents contain no evidence of business licenses, permits, regulatory registrations, or compliance certifications required for Helix Health Technologies to operate as a healthcare technology and services provider. While the company holds SOC 2 Type I certification and has executed Business Associate Agreements with all 42 clients, there is no documentation of state business licenses, professional certifications for staff, HIPAA authorization credentials, or any licenses necessary for the managed IT services, compliance consulting, and cybersecurity services the company offers. The absence of any license inventory, transferability analysis, or regulatory registration documentation represents a material compliance gap requiring immediate remediation before exit.	—
lc_02	Contract Change-of-Control Provisions Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Employee_Roster.csv · HTS_CIM.txt Helix Health Technologies has executed assignment-compliant customer agreements with documented change-of-control provisions; the Metro Orthopedic master subscription agreement explicitly permits assignment to a successor entity provided 60 days' notice is given, a new BAA is executed, and service levels are maintained. However, the documents provide no evidence of systematic legal review of all 42 client contracts for assignment language, vendor agreements (Epic integration, AWS), or lease terms, creating gaps in secondary agreement coverage. The company's internal process documentation focuses on BAA execution and HIPAA compliance but does not reference change-of-control provision assessment or assignment clause standardization across the contract portfolio.	7/10	ADEQUATE
lc_03	Employment Law Compliance Document evidence HTS_Employee_Roster.csv · HTS_HC_Profile.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Cybersecurity_Assessment.txt Helix Health Technologies maintains portable W-2 compensation structures (Anthem group health, Guardian dental/vision, Guideline 401(k), and documented unlimited PTO) with no equity plan for rank-and-file employees, but critical compliance documentation gaps exist. The CTO holds an 8% profits interest in Class B units with change-of-control acceleration provisions requiring buyout or renegotiation at close, and the documents contain no evidence of I-9 verification records, non-compete or non-solicitation agreements for technical staff (including the CTO who holds key vendor relationships), or formal employment classification documentation. Additionally, workforce HIPAA training is noted as "not formally documented" in the cybersecurity assessment, creating potential compliance exposure for a healthcare technology company.	6/10	ADEQUATE
lc_04	Intellectual Property Ownership Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Employee_Roster.csv · HTS_Cybersecurity_Assessment.txt Helix Health Technologies is formally incorporated as a Georgia LLC with clean entity-level ownership of core software IP, HIPAA-compliant infrastructure (AWS GovCloud, encryption, BAAs with all 42 clients), and portable benefits structures. However, IP ownership documentation lacks formal assignment agreements—the documents do not reference IP assignment schedules, trademark registrations, or an IP schedule in the data room—and the CTO holds critical architectural knowledge and vendor relationships (Epic integration, AWS environment) as a single point of failure, creating ambiguity about the transferability of technical IP and institutional knowledge at close.	6/10	ADEQUATE
lc_05	Litigation & Contingent Liability Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Cybersecurity_Assessment.txt · HTS_GL_Export.csv · HTS_CIM.txt Helix Health Technologies maintains current cyber liability and E&O insurance through Chubb (documented in January 2026 payroll records), and all 42 clients have executed Business Associate Agreements reflecting HIPAA compliance infrastructure. The company's external cybersecurity assessment identifies no material control failures, only maturity gaps such as SOC 2 Type II completion, workforce training documentation, and business continuity plan testing—all addressable within six months at modest cost—with an overall risk rating of "LOW-MEDIUM" and no disclosed litigation, claims, or contingent liabilities evident in the retrieved documents.	7/10	ADEQUATE

TMTechnology & Systems Maturity5.5/10 ADEQUATE (7% blend)

Evidence coverage: scored on 5 of 5 criteria

Deal Impact: Technology posture adequate with minor gaps — addressable before diligence without material timeline impact.

ID	Criterion & Finding	Score	Rating
tm_01	Core Systems Documentation & Ownership Document evidence HTS_HC_Profile.txt · HTS_Employee_Roster.csv · HTS_IT_Asset_Inventory.csv · HTS_Customer_Onboarding_SOP.txt · HTS_CIM.txt Helix Health Technologies has documented core systems including AWS GovCloud infrastructure, Okta SSO, GitHub Enterprise, and Snowflake, with entity-owned cloud credentials and MDM enrollment across devices. However, the CTO holds critical architectural knowledge and key vendor relationships (Epic integration, AWS HIPAA environment) as the primary technical risk, and the customer onboarding process identifies a key employee as the owner of technical assessment and platform configuration phases with no documented succession or knowledge transfer. Additionally, all 42 client relationships are mapped to the VP Customer Success's team for primary coverage, creating a dependency on specific individuals for business continuity despite the documented ability to survive a 4-week founder absence.	4/10	NEEDS WORK
tm_02	Cybersecurity & Data Protection Posture Document evidence HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_IT_Asset_Inventory.csv · HTS_GL_Export.csv Helix Health Technologies has deployed CrowdStrike Falcon EDR across all 18 endpoints with Intune MDM and automated patch management, and maintains current cyber liability and E&O insurance through Chubb with monthly premiums of $3,200. However, critical maturity gaps limit readiness: the incident response plan has not been updated since 2023, the business continuity plan has not been tested in 18 months with no documented runbook for AWS region failure, SOC 2 Type II certification remains incomplete (in progress), and no formal data retention/destruction policy is documented despite HIPAA requirements.	7/10	ADEQUATE
tm_03	Data Integrity & Business Intelligence Document evidence HTS_Cybersecurity_Assessment.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_CRM_Pipeline.csv · HTS_Employee_Roster.csv · HTS_Customer_Onboarding_SOP.txt Helix Health Technologies operates foundational data systems across CRM (HubSpot pipeline), financial tracking (Bookkeeper/Controller role), and customer platforms (Snowflake, AWS), but exhibits significant organizational dependencies and documentation gaps that impede reliable self-service reporting. The cybersecurity assessment identifies that workforce training completion records are "not formally tracked," data retention policy is "not formally documented," and business continuity plans have not been tested in 18 months, indicating that operational visibility depends heavily on individual knowledge holders rather than formalized, auditable systems. While the company maintains SOC 2 Type I certification and processes PHI for 42 covered entities, the absence of mature BI infrastructure, formal training documentation systems, and tested backup procedures reflects a stage where critical data exists but lacks the accessibility and independence from key personnel required for institutional reliability.	5/10	NEEDS WORK
tm_04	Technology Vendor & Subscription Management Document evidence HTS_HC_Profile.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Financials.csv · HTS_GL_Export.csv · HTS_CIM.txt · HTS_Cybersecurity_Assessment.txt Helix Health Technologies has documented core vendor relationships and subscription management for critical infrastructure—AWS GovCloud, Twilio, and Snowflake are tracked in the general ledger with entity-owned accounts—and all 42 client contracts include assignment provisions allowing transfer to a successor entity with 60 days' notice and BAA re-execution. However, the CTO holds the primary technical relationship with Epic integration and the AWS HIPAA environment as described in key employee risk documentation, and vendor renewal dates and a comprehensive license inventory are not formally documented in the retrieved materials, creating dependency risk on undocumented institutional knowledge.	6/10	ADEQUATE
tm_05	Technical Debt & Modernization Risk Document evidence HTS_Customer_Contract_MetroOrthopedic.txt · HTS_HC_Profile.txt · HTS_Cybersecurity_Assessment.txt · HTS_CIM.txt · HTS_AR_Aging.csv Helix Health Technologies operates on a cloud-based AWS HIPAA environment with modern HL7 FHIR R4 data export capability, but carries material technical debt and compliance maturity gaps that will require post-close buyer investment. The company has not yet completed SOC 2 Type II certification (targeted Q3 2026), lacks a tested business continuity plan for AWS region failure scenarios, and operates without privileged access management for production AWS access—instead relying on individual IAM credentials without hardware MFA tokens. Additionally, the CTO holds all EHR integration architecture knowledge across 14 third-party API relationships with no documented technical succession plan, creating operational risk that extends beyond infrastructure modernization.	5/10	NEEDS WORK

▲ Layer8's primary practice area. Technology & Systems Maturity is where Layer8 delivers directly — not just identifies gaps. Where this domain shows deficiencies, remediation is available immediately through Layer8 engagements.

HCHuman Capital5.7/10 ADEQUATE (12% blend)

Evidence coverage: scored on 5 of 5 criteria

ID	Criterion & Finding	Score	Rating
hc_01	Workforce Retention & Tenure Document evidence HTS_HC_Profile.txt · HTS_Employee_Roster.csv · HTS_CRM_Pipeline.csv Helix Health Technologies reports a 22% annual voluntary turnover rate over the rolling 24 months with average tenure of 3.2 years across all staff, though engineering turnover is elevated at 28% with two departures in 12 months (one mid-level engineer to Meta, one junior at 90 days) that caused a 6-week product release delay. Management and clinical teams demonstrate stability with 0% turnover among VP/Director-level staff and key roles like VP Customer Success operating independently for 12 months, though the CTO represents a critical technical and vendor relationship risk as the primary holder of architectural knowledge and Epic/AWS integration expertise.	5/10	NEEDS WORK
hc_02	Compensation Competitiveness Self-reported HTS_HC_Profile.txt · HTS_CIM.txt Helix Health Technologies benchmarks compensation annually against levels.fyi and Radford Global Technology Survey data, with most roles at or near market rates; however, senior engineers are positioned 6% below the levels.fyi median for Atlanta ($155K–$162K vs. $168K), and the company has no equity plan for rank-and-file employees despite relying on flexible work and mission culture as retention substitutes. The CTO holds a profits interest (8% economic, $180K–$240K value) with change-of-control acceleration that will require buyout or renegotiation at close, creating a known payroll cost liability for the buyer, while W-2 staff compensation itself is fully portable and non-inflationary.	6/10	ADEQUATE
hc_03	Recruiting & Training Capability Document evidence HTS_Customer_Onboarding_SOP.txt · HTS_HC_Profile.txt · HTS_CIM.txt · HTS_Cybersecurity_Assessment.txt Helix Health Technologies has documented hiring processes differentiated by function (engineering via LinkedIn/Georgia Tech, clinical via AMIA/HIMSS boards, implementation via referrals) with structured 3-round technical interviews, and an 8-week onboarding program with defined milestones for technical staff (60-day code quality review with CTO) and implementation staff (co-lead sign-off). However, founder or CTO approval remains required for all senior hires, and while new-hire 12-month retention stands at 78%, workforce training documentation is informal—the cybersecurity assessment identifies "annual HIPAA workforce training not formally documented" as a gap requiring implementation of a learning management system.	7/10	ADEQUATE
hc_04	Bench Depth & Succession Beyond Owner Document evidence HTS_HC_Profile.txt · HTS_Customer_Onboarding_SOP.txt · HTS_Cybersecurity_Assessment.txt Helix Health Technologies has identified the CTO as "the primary technical risk" holding "architectural knowledge and key vendor relationships (Epic integration, AWS HIPAA environment)" with no documented succession plan for this critical role. While the VP Customer Success has operated independently for 12 months and the company survived a 4-week founder absence in Q3 2025 without client disruption, the bench depth table shows "a key employee critical" status for Technical Architecture with only one backup listed as "a key employee — a key employee critical," indicating potential single points of failure remain and succession documentation for key non-owner technical positions is absent.	4/10	NEEDS WORK
hc_05	Compensation/Benefits Structure Transferability Document evidence HTS_HC_Profile.txt · HTS_Customer_Onboarding_SOP.txt · HTS_CIM.txt Helix Health Technologies maintains portable, entity-owned benefits (Anthem group health, Guardian dental/vision, Guideline 401(k), and documented unlimited PTO) with W-2 staff compensation fully documented and transferable. However, the CTO holds an 8% profits interest (Class B units) with a change-of-control acceleration provision estimated at $180,000–$240,000 that will require buyout or renegotiation at close, and Dr. A key employee holds a guaranteed payment plus Class A unit distributions—both owner-specific arrangements that create material cleanup complexity at exit.	6/10	ADEQUATE

Value Recovery RoadmapTotal Recoverable Value: $1,025,000

Prioritized by estimated recovery impact

Complete remediation plan across all scored domains. The Priority Fixes section above highlights the five ranked starting points.

Domain	Layer8 Service	Value at Risk	Est. Timeline	Typical Investment
CQCustomer Quality	Contract Audit & CRM Implementation	$215,250	⏱ 6–8 wks	$2,000 – $5,000
DRDiligence Risk	Security Hardening & Data Room Preparation	$174,250	⏱ 4–6 wks	$2,500 – $4,500
OROwner Risk	Succession Planning & Knowledge Capture Sprint	$164,000	⏱ 6–8 wks	$3,500 – $6,000
HCHuman Capital	Workforce Retention & Bench Depth Sprint	$123,000	⏱ 8–10 wks	$2,500 – $5,000
LCLegal & Regulatory Compliance	Legal Compliance Audit & Contract Review	$112,750	⏱ 4–6 wks	$1,500 – $3,500
OSOperational Scalability	Process Documentation & Systems Audit	$82,000	⏱ 8–10 wks	$4,000 – $7,000
FRFinancial Readiness	Books Cleanup & Add-Back Schedule	$82,000	⏱ 2–4 wks	$2,000 – $4,000
TMTechnology & Systems Maturity	Technology Infrastructure Audit & Modernization Plan	$71,750	⏱ 6–8 wks	$3,000 – $5,500
TOTAL		$1,025,000	—	$21,000 – $40,500

Typical investment ranges reflect market-rate remediation costs and are provided for prioritization purposes only. Actual engagement scope and pricing depend on business size, gap severity, and selected service provider. Layer8 Tech Group LLC provides formal engagement proposals following assessment delivery.

Ready to recover this value before you list?
Layer8 Tech Group LLC delivers these services for businesses preparing for acquisition.Schedule a Discovery Call →

Layer8 Service CatalogOne service per Roadmap row — purpose, inputs, deliverables, and success criteria

OSProcess Documentation & Systems Audit

addresses Operational Scalability · high buyer exposure

Purpose

Demonstrate to buyers that the business can operate and grow without the owner — the core test for platform acquisition suitability and a prerequisite for earn-out terms that don't require owner involvement.

Client Inputs

Existing process documentation (any format), list of core operational workflows, technology stack inventory, vendor contracts, org chart and current role descriptions.

Engagement Approach

Process mapping interviews with key staff, SOP drafting for undocumented workflows, technology stack documentation and gap assessment, vendor contract review, financial controls walkthrough and documentation.

Deliverables

Core SOP library covering sales, delivery, billing, and support; technology stack documentation; vendor contract summary with renewal calendar; financial controls memo; org chart with documented decision authority.

Success Criteria

A buyer's operations team can assess day-to-day execution from documentation alone; no single staff member is required to explain how the business runs; operations continue during a 30-day owner absence.

ORSuccession Planning & Knowledge Capture Sprint

addresses Owner Risk · high buyer exposure

Purpose

Convert undocumented succession risk into a written, buyer-acceptable transition plan that reduces Day 1 integration uncertainty and unlocks negotiation leverage on earn-out and escrow terms.

Client Inputs

Owner interview (2–3 hours), key staff interviews (1 hour each), access to current SOPs and operations documentation, current organizational chart.

Engagement Approach

Structured interview series capturing operational and relationship knowledge. Knowledge capture workshops with key staff. Drafting of formal succession plan with phased transition timeline and relationship handoff schedule.

Deliverables

Written succession plan (10–15 pages); phased 90-day transition timeline; key relationship introduction schedule; operational protocol handoff checklist; retention recommendations for critical staff.

Success Criteria

Plan reviewed and accepted by buyer counsel during diligence; transition timeline supports closing without operational disruption; no retention escrow required beyond standard market terms.

DRSecurity Hardening & Data Room Preparation

addresses Diligence Risk · high buyer exposure

Purpose

Eliminate the most common pre-close diligence findings — security gaps, disorganized documentation, and missing records — so the buyer's team moves efficiently and the seller enters negotiation with a clean record.

Client Inputs

Administrative access to email and file storage systems, current software and SaaS subscription list, contract inventory, data backup and recovery procedures.

Engagement Approach

Security posture assessment against buyer diligence checklists, MFA deployment verification, endpoint protection confirmation, data room folder structure built to standard buyer request formats, incident response procedure documented.

Deliverables

Organized data room with standard diligence folder structure; MFA confirmed across all systems; endpoint protection report; written incident response procedure; data backup and recovery procedure documented.

Success Criteria

Data room passes a sample buyer diligence checklist without gaps; security posture documented to buyer IT diligence standards; no security findings flagged during sale negotiations.

TMTechnology Infrastructure Audit & Modernization Plan

addresses Technology & Systems Maturity · high buyer exposure

Purpose

Produce the technology documentation and remediation roadmap buyers need to underwrite the business's systems without applying a 'black box' discount — demonstrating the tech stack is an asset, not a liability.

Client Inputs

List of all software, SaaS subscriptions, and hardware; IT vendor contracts; current cybersecurity policies; network or system architecture documentation; access to primary business applications for documentation.

Engagement Approach

Systems inventory and entity-ownership documentation, cybersecurity posture assessment, data integrity review, vendor rationalization, technical debt assessment, modernization roadmap drafting aligned to buyer integration requirements.

Deliverables

Complete systems inventory with entity-owned credential confirmation; cybersecurity findings report; data integrity assessment; vendor rationalization recommendations; written 18-month technology roadmap; technical debt disclosure memo.

Success Criteria

Buyer's IT diligence team can assess all systems from documentation alone; no critical vulnerabilities undisclosed; all material systems confirmed entity-owned and transferable; technical debt quantified and roadmap accepted by buyer's IT lead.

HCWorkforce Retention & Bench Depth Sprint

addresses Human Capital · high buyer exposure

Purpose

Demonstrate that key staff will remain post-close and that the business has the organizational depth to operate without the owner — reducing the escrow holdback and earn-out provisions buyers use to hedge staff attrition risk.

Client Inputs

Employee roster with tenure and compensation, org chart with reporting lines, existing employment or retention agreements, list of key non-owner roles, comp benchmarking data if available.

Engagement Approach

Compensation benchmarking against vertical market rates, retention risk assessment per key role, training playbook documentation, succession identification for critical non-owner positions, comp and benefits structure review for post-close transferability.

Deliverables

Compensation benchmarking report by role; retention risk matrix with recommended retention bonus structures; written succession plans for key non-owner roles; training playbook for top-3 operational roles; comp and benefits transferability memo.

Success Criteria

Buyer's HR diligence confirms comp is at or near market for all revenue-generating roles; retention agreements in place for staff with >20% of revenue exposure; succession paths documented for all roles where departure would disrupt operations within 90 days.

FRBooks Cleanup & Add-Back Schedule

addresses Financial Readiness · high buyer exposure

Purpose

Ensure the company's financial statements survive a Quality of Earnings review without re-trading — the single most common source of post-LOI price reductions in SMB transactions.

Client Inputs

3 years of P&L statements and balance sheets, accounting system access, list of all owner add-backs with supporting documentation, CPA contact.

Engagement Approach

Bookkeeping normalization review for consistency and GAAP alignment, add-back identification and documentation with evidentiary support, CPA coordination for reviewed or audited presentation, QofE preparation briefing.

Deliverables

Normalized 3-year P&L with documented add-backs; add-back schedule with supporting documentation for each item; buyer-defensible adjusted EBITDA calculation; QofE-ready financial package.

Success Criteria

Add-backs are documented with receipts or third-party statements that a buyer's QofE accountant will accept without pushback; EBITDA figure matches seller's stated number; no surprises in financial diligence.

LCLegal Compliance Audit & Contract Review

addresses Legal & Regulatory Compliance · moderate buyer exposure

Purpose

Surface and remediate the legal and compliance gaps that most commonly trigger post-LOI price reductions — license transferability, IP ownership, employment compliance, and undisclosed contingent liabilities.

Client Inputs

Business licenses and permits, material vendor and customer contracts, employment agreements and contractor arrangements, corporate formation documents, prior litigation or regulatory correspondence.

Engagement Approach

Business license review and transferability confirmation with counsel, contract assignment analysis, IP ownership confirmation, employment classification and I-9 review, litigation disclosure review and representation letter preparation.

Deliverables

Legal compliance memo covering all identified gaps and remediation actions; license transferability confirmation; contract assignment analysis; IP schedule; employment compliance findings; attorney representation letter.

Success Criteria

No open legal items triggering a material adverse change clause; licenses confirmed transferable by buyer's counsel; no IP ownership gaps; employment practices reviewed; litigation disclosure complete and documented.

CQContract Audit & CRM Implementation

addresses Customer Quality · moderate buyer exposure

Purpose

Protect revenue base transferability by ensuring customer contracts survive a change of control and the pipeline is visible to buyers — two of the most scrutinized items in lower-middle-market diligence.

Client Inputs

All active customer agreements, CRM access or pipeline export, renewal history, list of top 10 accounts by revenue.

Engagement Approach

Contract review for assignment and change-of-control clauses, gap remediation with M&A counsel for missing language, CRM selection or cleanup, pipeline workflow configuration, and renewal tracking implementation.

Deliverables

Contract assignment analysis with remediation recommendations; updated agreements with assignment language; CRM implementation with documented pipeline stages; weighted renewal forecast report.

Success Criteria

All material contracts include assignment language acceptable to buyer counsel; CRM shows a 90-day pipeline with documented renewal rates; top-10 account relationships documented with transition plans.

Ready to start a remediation sprint?
Layer8 Tech Group LLC delivers each of these services for businesses preparing for acquisition. Engagements are scoped to your timeline and deal target.Schedule a Discovery Call →

Automation Opportunity AssessmentScored separately — upside signals for post-close value creation, not deal-value drivers

▲ Automation Maturity IndexScored separately — excluded from overall score

5.0/10 (raw: 3/7)

Healthcare revenue infrastructure is evaluated on patient intake efficiency, appointment adherence automation, and recall sequences — all of which directly impact practice EBITDA and buyer valuation models.

Automation maturity is scored separately from the overall readiness score. The gaps below represent operational efficiency opportunities and post-close value creation for a buyer — not buyer discount risk.

#	Criterion & Finding	Score	Rating
R01	AI Voice / After-Hours Call Handling No evidence submitted · withheld from score HTS_Customer_Onboarding_SOP.txt · HTS_CIM.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt The retrieved documents contain no evidence of AI voice agent or automated after-hours call handling capabilities. The company's service offerings focus on patient engagement SaaS (appointment reminders, surveys, secure messaging), EHR integration, and managed IT services, with no mention of inbound call automation or voice AI technology.	—
R02	CRM Presence & Workflow Automation Document evidence HTS_HC_Profile.txt · HTS_CRM_Pipeline.csv · HTS_Cybersecurity_Assessment.txt · HTS_CIM.txt · HTS_Customer_Onboarding_SOP.txt The company uses HubSpot CRM with a documented sales pipeline tracking 15 deals across multiple stages and owners, but workflow automation is minimal and pipeline management is heavily dependent on individual salespeople (primarily Dr. A key employee and a key employee) with no evidence of automated lead nurturing, follow-up triggers, or systematic pipeline hygiene processes.	1/2	PARTIAL
R03	24/7 Lead Capture No evidence submitted · withheld from score HTS_Customer_Onboarding_SOP.txt · HTS_CRM_Pipeline.csv · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_Employee_Roster.csv · HTS_Cybersecurity_Assessment.txt · HTS_IT_Asset_Inventory.csv The retrieved documents contain no evidence of after-hours or 24/7 lead capture capabilities; all customer acquisition and onboarding processes are manual and owner-dependent, with no mention of contact forms, chatbots, or automated lead routing systems.	—
R04	SMS Appointment Reminders & Confirmations Document evidence HTS_Customer_Onboarding_SOP.txt · HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt · HTS_GL_Export.csv · HTS_CIM.txt The company has implemented SMS delivery capability as part of its patient engagement platform (evidenced by Twilio COGS of $2,800 in March 2025 and SMS testing in Phase 4 of onboarding), but documentation does not demonstrate a fully automated SMS appointment reminder and confirmation workflow—only that "outbound message testing — SMS and email delivery" occurs during client implementation, suggesting manual or inconsistent configuration rather than a systematized, buyer-ready automation sequence.	1/2	PARTIAL
R05	Automated Review Solicitation No evidence submitted · withheld from score HTS_Cybersecurity_Assessment.txt · HTS_HC_Profile.txt · HTS_CIM.txt The retrieved documents contain no evidence of any post-service review solicitation capability, whether manual or automated. The company's service offerings and operational processes are documented across security, HR, and financial sections, but review request workflows are not mentioned, indicating this function is either absent or entirely organic.	—
R06	Smart Follow-Up Sequences No evidence submitted · withheld from score HTS_Customer_Onboarding_SOP.txt · HTS_Customer_Contract_MetroOrthopedic.txt · HTS_CIM.txt · HTS_Cybersecurity_Assessment.txt · HTS_Employee_Roster.csv The retrieved documents contain no evidence of automated follow-up sequences for leads or dormant clients; the onboarding SOP focuses only on initial client implementation phases, and there is no mention of lead nurturing, drip campaigns, or re-engagement automation in any operational or CRM documentation.	—

No automation maturity band is published for this company. 2 of 6 criteria were scored; 4 had no evidence in the material provided, and a band selected from the remainder would describe the criteria that happened to be answerable rather than the revenue infrastructure.

► Operational Automation OpportunitiesVertical-specific — excluded from overall score

0.8/10MANUAL (raw: 1/12)

Vertical-specific operational automation gaps identified in Healthcare Operational Automation operations. These gaps represent immediate efficiency opportunities for the current owner and post-close value creation levers for a buyer.

Operational automation gaps identified below are framed as efficiency and revenue recovery opportunities. Dollar estimates reflect operational impact, not a valuation adjustment. Layer8 delivers these implementations directly.

Automation Opportunity	Score	Status	Layer8 Opportunity
Patient Intake & Registration	0/2	MANUAL	Digital intake automation eliminates an average of 8-12 minutes of staff time per patient visit and reduces data entry errors that trigger claim denials.
Insurance Eligibility Verification	0/2	MANUAL	Automated eligibility verification reduces claim denials by 30-40% and eliminates the most common source of front-desk staff overtime.
Referral Tracking & Follow-Up	0/2	MANUAL	Referral loop closure automation improves continuity of care documentation and reduces liability exposure from lost referrals — a common finding in healthcare acquisitions.
Billing Exception & Denial Management	0/2	MANUAL	Denial management automation typically recovers 3-6% of gross charges that would otherwise be written off — directly expanding EBITDA margin.
Staff Credentialing & License Renewal	0/2	MANUAL	Credentialing automation eliminates the compliance liability of expired provider credentials — a finding that can trigger payer audits and delay healthcare acquisitions significantly.
Patient Satisfaction & Quality Measure Automation	1/2	PARTIAL	Automated quality measure tracking supports value-based care contracts and demonstrates clinical performance to buyers — increasingly a premium multiple driver in healthcare M&A.

Ready to build your automation infrastructure before you list?
Layer8 runs 90-day Automation Sprints that close AMI gaps and systematize vertical-specific workflows — on a defined scope and a fixed timeline.Schedule a Discovery Call →

Compliance Notes

PII was detected and redacted in 9 document(s) prior to ingestion:

HTS_CIM.txt: PERSON
HTS_CRM_Pipeline.csv: PERSON
HTS_Customer_Contract_MetroOrthopedic.txt: PERSON
HTS_Customer_Onboarding_SOP.txt: PERSON
HTS_Employee_Roster.csv: PERSON
HTS_Financials.csv: PHONE_NUMBER
HTS_GL_Export.csv: PERSON
HTS_HC_Profile.txt: PERSON
HTS_IT_Asset_Inventory.csv: PERSON